The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Efficacy of pneumococcal vaccination in adults: a meta-analysis
Open accessAbstract
BACKGROUND: Clinical trials and meta-analyses have produced conflicting results of the efficacy of unconjugated pneumococcal polysaccharide vaccine in adults. We sought to evaluate the vaccine's efficacy on clinical outcomes as well as the methodologic quality of the trials. METHODS: We searched several databases and all bibliographies of reviews and meta-analyses for clinical trials that compared pneumococcal polysaccharide vaccine with a control. We examined rates of pneumonia and death, taking the methodologic quality of the trials into consideration. RESULTS: We included 22 trials involving 101 507 participants: 11 trials reported on presumptive pneumococcal pneumonia, 19 on all-cause pneumonia and 12 on all-cause mortality. The current 23-valent vaccine was used in 8 trials. The relative risk (RR) was 0.64 (95% confidence interval [CI] 0.43-0.96) for presumptive pneumococcal pneumonia and 0.73 (95% CI 0.56-0.94) for all-cause pneumonia. There was significant heterogeneity between the trials reporting on presumptive pneumonia (I(2) = 74%, p < 0.001) and between those reporting on all-cause pneumonia (I(2) = 90%, p < 0.001). The RR for all-cause mortality was 0.97 (95% CI 0.87-1.09), with moderate heterogeneity between trials (I(2) = 44%, p = 0.053). Trial quality, especially regarding double blinding, explained a substantial proportion of the heterogeneity in the trials reporting on presumptive pneumonia and all-cause pneumonia. There was little evidence of vaccine protection in trials of higher methodologic quality (RR 1.20, 95% CI 0.75-1.92, for presumptive pneumonia; and 1.19, 95% CI 0.95-1.49, for all-cause pneumonia in double-blind trials; p for heterogeneity > 0.05). The results for all-cause mortality in double-blind trials were similar to those in all trials combined. There was little evidence of vaccine protection among elderly patients or adults with chronic illness in analyses of all trials (RR 1.04, 95% CI 0.78-1.38, for presumptive pneumococcal pneumonia; 0.89, 95% CI 0.69-1.14, for all-cause pneumonia; and 1.00, 95% CI 0.87-1.14, for all-cause mortality). INTERPRETATION: Pneumococcal vaccination does not appear to be effective in preventing pneumonia, even in populations for whom the vaccine is currently recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Self-citationMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Self-citationAssessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309 · cited 3×
“Empirical evidence and theoretical considerations support the notion that trials of higher methodologic quality will provide results closer to the truth than lower quality trials will.(23,57,58) Meta-analysis cannot prove that this is necessarily the case here, since other factors associated with both the quality of t…”
BackgroundResultSelf-citationWood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538 · cited 2×
“This is in accordance with recent research that examined 146 meta-analyses of clinical trials with a range of outcomes.(60) In trials with subjective outcomes, effect estimates were exaggerated when there was no blinding or the concealment of allocation was inadequate; however, there was little evidence of bias in tri…”
ResultSelf-citationPrognosis and Outcomes of Patients With Community-Acquired Pneumonia: A Meta-analysis
Fine, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03530260048030 · Cited by 1,310
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,051
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Lexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671
The Coronary Drug Project Research Group (1980) · New England Journal of Medicine · doi:10.1056/nejm198010303031804 · Cited by 659
Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
Jackson, L. A., Neuzil, K. M., Yu, O., Benson, P., Barlow, W. E., Adams, A. L., Hanson, C. A., Mahoney, L. D., Shay, D. K., & Thompson, W. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022678 · Cited by 608
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review
Jefferson, T., Rivetti, D., Rivetti, A., Rudin, M., Di Pietrantonj, C., & Demicheli, V (2005) · The Lancet · doi:10.1016/s0140-6736(05)67339-4 · Cited by 601
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G. (1945) · Journal of Experimental Medicine · doi:10.1084/jem.82.6.445 · Cited by 518
French, N., Nakiyingi, J., Carpenter, L., Lugada, E., Watera, C., Moi, K., Moore, M., Antvelink, D., Mulder, D., Janoff, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02377-1 · Cited by 461
7. Prevention of Pneumococcal Pneumonia by Vaccination
Austrian, R., Douglas, R. M., Schiffman, G., Coetzee, A. M., Koornhof, H. J., Hayden-Smith, S., & Reid, R. D. W. (1985) · Life with the Pneumococcus · doi:10.9783/9781512800135-009 · Cited by 401
Adherence to Treatment and Health Outcomes
Horwitz, R. I. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.16.1863 · Cited by 400
Efficacy of Pneumococcal Vaccine in High-Risk Patients
Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geiseler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., Shepard, D. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152104 · Cited by 395
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub2 · Cited by 387
Örtqvist, Å., Hedlund, J., Burman, L.-Å., Elbel, E., Höfer, M., Leinonen, M., Lindblad, I., Sundelöf, B., & Kalin, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07358-3 · Cited by 376
Efficacy of Pneumococcal Vaccination in Adults: A Meta-analysis of Randomized Controlled Trials
Fine, M. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420230051007 · Cited by 370
Protective Efficacy of Pneumococcal Polysaccharide Vaccines
Smit, P. (1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03280250039019 · Cited by 350
Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis
Fine, M. J. (1996) · JAMA · doi:10.1001/jama.275.2.134 · Cited by 337
The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
SIMS, R. V., STEINMANN, W. C., MCCONVILLE, J. H., KING, L. R., ZWICK, W. C., & SCHWARTZ, J. S. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-653 · Cited by 317
Bacteriology of Hospital-Acquired Pneumonia
Bartlett, J. G. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.5.868 · Cited by 268
Clinical efficacy of anti-pneumococcal vaccination in patients with COPD
Alfageme, I. (2006) · Thorax · doi:10.1136/thx.2005.043323 · Cited by 233
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
Koivula, I., Stén, M., Leinonen, M., & Mäkelä, P. H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00149-6 · Cited by 217
Schneider, E. C., Cleary, P. D., Zaslavsky, A. M., & Epstein, A. M. (2001) · JAMA · doi:10.1001/jama.286.12.1455 · Cited by 203
Melegaro, A., & Edmunds, W. J. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000024701.94769.98 · Cited by 185 · cited 2×
“Several meta-analyses reported protective effects of the vaccine on all-cause pneumonia in subgroups, for example lowrisk groups or populations from lower income countries.(11,16,19)”
BackgroundResultIMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE
Riley, I. D., Andrews, M., Howard, R., Tarr, P. I., Pfeiffer, M., Challands, P., Jennison, G., & Douglas, R. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92552-1 · Cited by 184
Cornu, C., Yzèbe, D., Léophonte, P., Gaillat, J., Boissel, J. P., & Cucherat, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00217-1 · Cited by 166
Honkanen, P. O., Keistinen, T., Miettinen, L., Herva, E., Sankilampi, U., Läärä, E., Leinonen, M., Kivelä, S.-L., & Helena Mäkelä, P. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00069-9 · Cited by 161
Magnitude, Duration, Quality, and Function of Pneumococcal Vaccine Responses in Elderly Adults
Rubins, J. B., Puri, A. K. G., Loch, J., Charboneau, D., MacDonald, R., Opstad, N., & Janoff, E. N. (1998) · The Journal of Infectious Diseases · doi:10.1086/515644 · Cited by 141
Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults
Watson, L. C., Wilson, B. J., & Waugh, N. R. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00112-3 · Cited by 131
Granger, R. H., Walters, J. A., Poole, P., Lasserson, T. J., Mangtani, P., Cates, C. J., & Wood-Baker, R. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001390.pub2 · Cited by 130
Mangtani, P., Cutts, F. T., & Hall, A. J. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00514-0 · Cited by 129
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
Moore, R. A., Wiffen, P. J., & Lipsky, B. A. (2000) · BMC Family Practice · doi:10.1186/1471-2296-1-1 · Cited by 127
Kaufman, P. (1947) · Archives of Internal Medicine · doi:10.1001/archinte.1947.00220110058004 · Cited by 123
Pneumococcal vaccines for sickle cell disease
Davies, E. G., Hirst, C., Lottenberg, R., & Dower, N. A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003885.pub2 · Cited by 122
Conaty, S. J., Watson, L. C., Dinnes, J., & Waugh, N. R. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.08.050 · Cited by 118
Anti-pneumococcal antibody response in normal subjects: A meta-analysis
Go, E., & Ballas, Z. K. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70244-0 · Cited by 117
[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].
GAILLAT, J., Zmirou‐Navier, D., Mallaret, M., Rouhan, D., Bru, J. P., Stahl, J. ‐., Delormas, P., & Micoud, M. (1985) · PubMed · Cited by 115
Chalmers, I. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.5.1156 · Cited by 112
Fortnightly Review: The pneumococcal problem
Obaro, S., Monteil, M., & Henderson, D. C. (1996) · BMJ · doi:10.1136/bmj.312.7045.1521 · Cited by 106
Clinical effectiveness of pneumococcal vaccine. Meta-analysis.
Hutchison, B. G., Oxman, A., Shannon, H. S., Lloyd, S., Altmayer, C. A., & Thomas, K. (1999) · PubMed Central · Cited by 104
Davis, A. L., Aranda, C. P., Schiffman, G., & Christianson, L. C. (1987) · CHEST Journal · doi:10.1378/chest.92.2.204 · Cited by 103
Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.
Leech, J., Gervais, A., & Ruben, F. L. (1987) · Europe PMC (PubMed Central) · Cited by 88
Pneumococcal vaccination during pregnancy for preventing infant infection
Chaithongwongwatthana, S., Yamasmit, W., Limpongsanurak, S., Lumbiganon, P., & Tolosa, J. E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004903.pub4 · Cited by 83
Pneumococcal vaccines for children and adults with bronchiectasis
Chang, C. C., Singleton, R. J., Morris, P. S., & Chang, A. B. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006316.pub3 · Cited by 83
Estimating the effects of misclassification
Mertens, T. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92820-j · Cited by 82
Walters, J. A., Smith, S., Poole, P., Granger, R. H., & Wood-Baker, R. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001390.pub3 · Cited by 76
Does Skepticism Towards Medical Care Predict Mortality?
Fiscella, K. A., Franks, P. J., Clancy, C. M., Doescher, M. P., & Banthin, J. S. (1999) · Medical Care · doi:10.1097/00005650-199904000-00010 · Cited by 67
Racial and ethnic disparities in influenza vaccination among elderly adults
Rangel, M. C., Schoenbach, V. J., Weigle, K. A., Hogan, V. K., Strauss, R. P., & Bangdiwala, S. I. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0097.x · Cited by 63
Pneumococcal vaccine for asthma
Sheikh, A., Alves, B., & Dhami, S. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002165 · Cited by 57
Steentoft, J., Konradsen, H. B., HILSKOV, J., Gislason, G., & Andersen, J. R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.020 · Cited by 51
Wagner, C., Popp, W., Posch, M., Vlasich, C., & Rosenberger-Spitzy, A. (2003) · Gerontology · doi:10.1159/000070405 · Cited by 51
Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma
Klastersky, J., Mommen, P., Cantraine, F. R. L., & Safary, A. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90367-6 · Cited by 46
Efectividad de la vacuna frente al neumococo en el anciano. Revisión sistemática y metaanálisis
Puig‐Barberà, J., Belenguer‐Varea, Á., Pinto, M. G., & Benlliure, M. J. B. (2002) · Atención Primaria · doi:10.1016/s0212-6567(02)79027-6 · Cited by 33
Gerber, S., Tallon, D., Trelle, S., Schneider, M., Jüni, P., & Egger, M. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.10.022 · Cited by 27
Self-citationNoakes, K., Pebody, R. G., Gungabissoon, U., Stowe, J., & Miller, E. (2006) · Journal of Public Health · doi:10.1093/pubmed/fdl017 · Cited by 27
Fedson, D. S. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00604-2 · Cited by 13
Cited by
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
Bonten, M. J. M., Huijts, S. M., Bolkenbaas, M., Webber, C., Patterson, S., Gault, S., van Werkhoven, C. H., van Deursen, A. M. M., Sanders, E. A. M., Verheij, T. J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408544 · Cited by 1,248
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
van Assen, S., Agmon-Levin, N., Elkayam, O., Cervera, R., Doran, M. F., Dougados, M., Emery, P., Geborek, P., Ioannidis, J. P. A., Jayne, D. R. W., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137216 · Cited by 630
Burden of Community-Acquired Pneumonia in North American Adults
File, T. M., & Marrie, T. J. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.03.2130 · Cited by 472
Panagiotou, O. A., Contopoulos-Ioannidis, D. G., & Ioannidis, J. P. A. (2013) · BMJ · doi:10.1136/bmj.f707 · Cited by 89
Metadata
- Authors
- Huss, A., Scott, P., Stuck, A. E., Trotter, C., & Egger, M.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2009-01-06
- Volume
- 180
- Issue
- 1
- Pages
- 48-58
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2110155476
- Cited by
- 414
- References
- 61
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.